149 related articles for article (PubMed ID: 38468248)
21. Combined histopathological risk score using TP53 protein expression, CD8
Chen W; Farchoukh L; Seigh L; Hartman DJ; Pai RK
Histopathology; 2021 Nov; 79(5):826-835. PubMed ID: 34121230
[TBL] [Abstract][Full Text] [Related]
22. Functional status and spatial interaction of T cell subsets driven by specific tumor microenvironment correlate with recurrence of non-small cell lung cancer.
Yang L; Zhang W; Sun J; Yang G; Cai S; Sun F; Xing L; Sun X
Front Immunol; 2022; 13():1022638. PubMed ID: 36685566
[TBL] [Abstract][Full Text] [Related]
23. The effect of neoadjuvant therapy on PD-L1 expression and CD8+lymphocyte density in non-small cell lung cancer.
Zens P; Bello C; Scherz A; von Gunten M; Ochsenbein A; Schmid RA; Berezowska S
Mod Pathol; 2022 Dec; 35(12):1848-1859. PubMed ID: 35915139
[TBL] [Abstract][Full Text] [Related]
24. High Stromal TGFBI in Lung Cancer and Intratumoral CD8-Positive T Cells were Associated with Poor Prognosis and Therapeutic Resistance to Immune Checkpoint Inhibitors.
Nakazawa N; Yokobori T; Kaira K; Turtoi A; Baatar S; Gombodorj N; Handa T; Tsukagoshi M; Ubukata Y; Kimura A; Kogure N; Ogata K; Maeno T; Sohda M; Yajima T; Shimizu K; Mogi A; Kuwano H; Saeki H; Shirabe K
Ann Surg Oncol; 2020 Mar; 27(3):933-942. PubMed ID: 31571056
[TBL] [Abstract][Full Text] [Related]
25. Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches.
Parra ER; Villalobos P; Behrens C; Jiang M; Pataer A; Swisher SG; William WN; Zhang J; Lee J; Cascone T; Heymach JV; Forget MA; Haymaker C; Bernatchez C; Kalhor N; Weissferdt A; Moran C; Zhang J; Vaporciyan A; Gibbons DL; Sepesi B; Wistuba II
J Immunother Cancer; 2018 Jun; 6(1):48. PubMed ID: 29871672
[TBL] [Abstract][Full Text] [Related]
26. [Effect of Pembrolizumab on T Lymphocyte Subsets in Patients with Advanced
Non-small Cell Lung Cancer and Its Therapeutic Effect].
Wang Y; Wang Y; Jiang M; Zhao Y; Zhang X
Zhongguo Fei Ai Za Zhi; 2021 Mar; 24(3):182-187. PubMed ID: 33819968
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of immunoscore related markers in bladder cancer.
Ariafar A; Sanati A; Ahmadvand S; Shekarkhar G; Safaei A; Shayan Z; Faghih Z
BMC Urol; 2022 Aug; 22(1):133. PubMed ID: 36038861
[TBL] [Abstract][Full Text] [Related]
28. Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy.
de Groot AF; Blok EJ; Charehbili A; Engels CC; Smit VTHBM; Dekker-Ensink NG; Putter H; Meershoek-Klein Kranenbarg E; van de Velde CJH; Liefers GJ; Nortier JWR; Kuppen PJK; van der Burg SH; Kroep JR
Breast Cancer Res Treat; 2019 Jun; 175(3):605-615. PubMed ID: 30868392
[TBL] [Abstract][Full Text] [Related]
29. Intratumoral CXCL13
Dai S; Zeng H; Liu Z; Jin K; Jiang W; Wang Z; Lin Z; Xiong Y; Wang J; Chang Y; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Qu Y; Guo J; Xu J
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589528
[TBL] [Abstract][Full Text] [Related]
30. CD3+ CD4+ and CD3+ CD8+ lymphocyte subgroups and their surface receptors NKG2D and NKG2A in patients with non-small cell lung cancer.
Yu DP; Han Y; Zhao QY; Liu ZD
Asian Pac J Cancer Prev; 2014; 15(6):2685-8. PubMed ID: 24761885
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics.
Karpathiou G; Casteillo F; Giroult JB; Forest F; Fournel P; Monaya A; Froudarakis M; Dumollard JM; Prades JM; Peoc'h M
Oncotarget; 2017 Mar; 8(12):19310-19322. PubMed ID: 28038471
[TBL] [Abstract][Full Text] [Related]
32. Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy.
Li H; Yu H; Lan S; Zhao D; Liu Y; Cheng Y
Technol Cancer Res Treat; 2021; 20():15330338211039948. PubMed ID: 34851203
[No Abstract] [Full Text] [Related]
33. Infiltration by Intratumor and Stromal CD8 and CD68 in Cervical Cancer.
Dimitrova P; Vasileva-Slaveva M; Shivarov V; Hasan I; Yordanov A
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109686
[No Abstract] [Full Text] [Related]
34. Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma.
Zhang H; AbdulJabbar K; Moore DA; Akarca A; Enfield KSS; Jamal-Hanjani M; Raza SEA; Veeriah S; Salgado R; McGranahan N; Le Quesne J; Swanton C; Marafioti T; Yuan Y
Cancer Res; 2023 May; 83(9):1410-1425. PubMed ID: 36853169
[TBL] [Abstract][Full Text] [Related]
35. Infiltration of CD4, CD8, CD56, and Fox-P3-positive lymphocytes in breast carcinoma tissue after neoadjuvant chemotherapy with or without trastuzumab.
Itoi N; Umeda T; Ishida M; Murata S; Mori T; Kawai Y; Tomida K; Shimizu T; Kushima R; Tani M
Breast Dis; 2019; 38(2):57-65. PubMed ID: 31006655
[TBL] [Abstract][Full Text] [Related]
36. Tumor-infiltrating CD8(+) T lymphocytes associated with clinical outcome in anal squamous cell carcinoma.
Hu WH; Miyai K; Cajas-Monson LC; Luo L; Liu L; Ramamoorthy SL
J Surg Oncol; 2015 Sep; 112(4):421-6. PubMed ID: 26287957
[TBL] [Abstract][Full Text] [Related]
37. High CD8
Koemans WJ; van Dieren JM; van den Berg JG; Meijer GA; Snaebjornsson P; Chalabi M; Lecot F; Riedl R; Krijgsman O; Hofland I; Broeks A; Voncken FEM; Peppelenbosch MP; Sosef MN; van Sandick JW; Kodach LL
Histopathology; 2021 Aug; 79(2):238-251. PubMed ID: 33660299
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Relevance of the Relative Presence of CD4, CD8 and CD20 Expressing Tumor Infiltrating Lymphocytes in Operable Non-small Cell Lung Cancer Patients.
Giatromanolaki A; Anestopoulos I; Panayiotidis MI; Mitrakas A; Pappa A; Koukourakis MI
Anticancer Res; 2021 Aug; 41(8):3989-3995. PubMed ID: 34281863
[TBL] [Abstract][Full Text] [Related]
39. Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.
Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; Du Z
Digestion; 2012; 86(4):329-37. PubMed ID: 23207161
[TBL] [Abstract][Full Text] [Related]
40. Ki67 expression and localization of T cells after neoadjuvant therapies as reliable predictive markers in rectal cancer.
Imaizumi K; Suzuki T; Kojima M; Shimomura M; Sakuyama N; Tsukada Y; Sasaki T; Nishizawa Y; Taketomi A; Ito M; Nakatsura T
Cancer Sci; 2020 Jan; 111(1):23-35. PubMed ID: 31660687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
